Executive summary of the japan atherosclerosis society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 version

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 6, 2013, Pages 517-523

  Teramoto, Tamio ^a   Sasaki, Jun ^a   Ishibashi, Shun ^a   Birou, Sadatoshi ^a   Daida, Hiroyuki ^a   Dohi, Seitaro ^a   Egusa, Genshi ^a   Hiro, Takafumi ^a   Hirobe, Kazuhiko ^a   Iida, Mami ^a   Kihara, Shinji ^a   Kinoshita, Makoto ^a   Maruyama, Chizuko ^a   Ohta, Takao ^a   Okamura, Tomonori ^a   Yamashita, Shizuya ^a   Yokode, Masayuki ^a   Yokote, Koutaro ^a  

^a Committee for Epidemiology and Clinical Management of Atherosclerosis ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; EZETIMIBE; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID DERIVATIVE; PROBUCOL; TRIACYLGLYCEROL;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); MORTALITY; NOTE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SECONDARY PREVENTION;

ADULT; AGED; ATHEROSCLEROSIS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; JAPAN; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS; SOCIETIES, MEDICAL;

EID: 84879464821     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.15792     Document Type: Note

References (13)

1. Imano H, Noda H, Kitamura A, Sato S, Kiyama M, Sankai T, Ohira T, Nakamura M, Yamagishi K, Ikeda A,Shimamoto T, Iso H: Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: the Circulatory Risk in Communities Study (CIRCS). Prev Med, 2011; 52: 381-386
2. Saito I, Folsom AR, Aono H, Ozawa H, Ikebe T, Yamashita T: Comparison of fatal coronary heart disese occurrence based on population surveys in Japan and the USA. Int J Epidemiol, 2000; 29: 837-844
3. Menotti A, Blackburn H, Kromhout D, Nissinen A, Fidanza F, Giampaoli S, Buzina R, Mohacek I, Nedeljkovic S, Aravanis C, Toshima H: Changes in population cholesterol levels and coronary heart disease deaths in seven countries, Eur Heart J, 1997; 18: 566-571
4. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using riskfactor categories. Circulation, 97: 1837-1847, 1998
5. Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folsom AR, Sato S, Kiyama M, Nakamura M, Sankai T: Highdensity lipoprotein cholesterol and premature coronary heart disease in urban Japanese men, Circulation, 1994; 89: 2533-2539
6. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia: primary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J, 2002; 66: 1087-1095
7. Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intevention Trial: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Tr(la J-LIT). Circ J, 2002; 66: 1096-1100
8. Verschuren WM, Jacobs DR, Bloemberg BP, Bloemberg BPM, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Nedelijković S, Nissinen A, Toshima H: Serum total cholesterol and long-term coronary heart disease mortality in different cultures: twenty five-year follow-up of the seven countries study. JAMA, 1995; 274: 131-136
9. Hirobe K, Terai T, Fujioka S, Goto K, Dohi S; 3M-Study Project Committee of the Japan Association of Occupational Physicians "San-yu-kai": Morbidity of Myocardial Infarction Multicenter Study in Japan (3M Study): study design and event rates for myocardial infarction and coronary death by age category in Japanese workers. Circ J, 2005; 69: 767-773
10. Okamura T, Tanaka H, Miyamatsu N, Hayakawa T, Kadowaki T, Kita Y, Nakamura Y, Okayama A, Ueshima H; NIPPON DATA80 Research Group. The relationship between serum total cholesterol and all-cause or causespecific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis, 2007; 190: 216-223
11. NIPPON DATA80 Research Group. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J, 2006; 70: 1249-1255
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-2497
13. Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Perrone Filardi P, Riccardi G, Storey RF, Wood D; ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis, 2011; 217 Suppl 1: S1-44